Postoperative Pain for Patients After TA-BSM

May 25, 2024 updated by: Wenlong Yao (101480)

Effect of Thoracic Paravertebral Nerve Block on Postoperative Pain After Transapical Beating-heart Myectomy(TA-BSM) in Patients With Hypertrophic Obstructive Cardiomyopathy: a Retrospective Cohort Study

To retrospectively analyze the intraoperative and postoperative status of patients with hypertrophic cardiomyopathy undergoing TA-BSM, and to estimate whether paravertebral nerve block can improve postoperative pain for these patients.

Study Overview

Detailed Description

Since conventional septal myectomy can be only assessed when the heart resumes beating, and the complications induced by cardiopulmonary bypass are inevitable, a novel transapical beating-heart septal myectomy (TA-BSM) has been invented, which provides real-time evaluation to guide resection while reducing surgical trauma. Postoperative pain after TA-BSM is unknown. Whether paravertebral nerve block can improve postoperative pain caused by TA-BSM is the objective of our study.

Study Type

Observational

Enrollment (Actual)

197

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430030
        • Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The information of all patients with hypertrophic cardiomyopathy undergoing TA-BSM in our hospital from April 2023 to September 2023 was extracted and screened according to the inclusion criteria and exclusion criteria.

Description

Inclusion Criteria:

  • Age 18~75 years
  • American society of anesthesiologists classification II-III
  • Elective TA-BSM was performed

Exclusion Criteria:

  • Underwent multiple surgical procedures or required cardiopulmonary bypass assistance
  • Combined other function decompensation disease
  • Patients with incomplete medical records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
group GA+PVB
The patients received General Anesthesia(GA) combined with Paravertebral Block(PVB).
Thoracic paravertebral block was performed before surgery
group GA only
The patients received general anesthesia only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Morphine consumption
Time Frame: During the first 48 hours after surgery
Cumulative morphine consumption
During the first 48 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain score 1
Time Frame: 24 hours after surgery and and 48 hours after surgery
Visual Analogue Scale score(0-10 stands for the degree of pain, 0=no pain, 10=the worst pain ever)
24 hours after surgery and and 48 hours after surgery
Postoperative pain score 2
Time Frame: Day 7 after surgery and month 3 after surgery
Brief Pain Inventory(The degree of pain [0 no pain to 10 very painful] and the impact of pain on daily life function [0 no impact to 10 very impact])
Day 7 after surgery and month 3 after surgery
Physical recovery after surgery
Time Frame: Day 7 after surgery
Quality of recovery(Rating from 0 [very poor] to 150 [excellent])
Day 7 after surgery
Complications
Time Frame: 24 hours and 48 hours after surgery
The incidence of nausea and vomiting
24 hours and 48 hours after surgery
Perioperative information 1
Time Frame: Immediately after the surgery
The usage of analgesic drug
Immediately after the surgery
Perioperative information 2
Time Frame: P1= before induction, P2= 5 minutes after tracheal intubation, P3= before skin incision, P4= 5 minutes after skin incision, P5=5 minutes after placed the rib spreader
Mean arterial blood pressure
P1= before induction, P2= 5 minutes after tracheal intubation, P3= before skin incision, P4= 5 minutes after skin incision, P5=5 minutes after placed the rib spreader
Perioperative information 3
Time Frame: P1= before induction, P2= 5 minutes after tracheal intubation, P3= before skin incision, P4= 5 minutes after skin incision, P5=5 minutes after placed the rib spreader
Heart reat
P1= before induction, P2= 5 minutes after tracheal intubation, P3= before skin incision, P4= 5 minutes after skin incision, P5=5 minutes after placed the rib spreader
Perioperative information 4
Time Frame: Immediately after the surgery
Duration of anesthesia
Immediately after the surgery
Postoperative information 1
Time Frame: Postoperative in 24 hours
Extubation time
Postoperative in 24 hours
Postoperative information 2
Time Frame: Postoperative in 48 hours
The usage of analgesic drug
Postoperative in 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wenlong Yao, Tongji Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

May 11, 2024

First Submitted That Met QC Criteria

May 25, 2024

First Posted (Actual)

May 29, 2024

Study Record Updates

Last Update Posted (Actual)

May 29, 2024

Last Update Submitted That Met QC Criteria

May 25, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • TJMZK230601

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nerve Block

Clinical Trials on Thoracic paravertebral block

Subscribe